Sector specialization is a key differentiator for Nordic Capital, believes Klas Tikkanen, the firm's Chief Operating Officer: "I don't think many buyout managers have teams dedicated solely to the pharmaceutical or MedTech sectors". He also emphasizes the firm's "very proactive approach to investment sourcing".